Jingmeng Liu

机构：Shanghai Jiao Tong University, Wenzhou Medical University, Ruijin Hospital, World Wide Web Consortium, Shanghai Institute of Hematology · ORCID：0000-0002-2218-9380

发表论文 17 篇 · 总被引 129 次 · h-index 6

代表论文

• Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus (2021 · Cardiovascular Diabetology · 被引 59)
• Senescent CD8+ T cells: a novel risk factor in atrial fibrillation (2024 · Cardiovascular Research · 被引 17)
• Nuclear receptor Dax1 promotes atherosclerosis by lipid transport inhibition and autophagy suppression in macrophages (2025 · European Heart Journal · 被引 13)
• Serum secreted phosphoprotein 1 level is associated with plaque vulnerability in patients with coronary artery disease (2024 · Frontiers in Immunology · 被引 13)
• Promoting collateral formation in type 2 diabetes mellitus using ultra-small nanodots with autophagy activation and ROS scavenging (2024 · Journal of Nanobiotechnology · 被引 10)
• Plasma myeloperoxidase: association with atrial fibrillation progression and recurrence after catheter ablation (2023 · Frontiers in Cardiovascular Medicine · 被引 6)